{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:27:48Z","timestamp":1794320868216,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10557"],"award-info":[{"award-number":["PG\/21\/10557"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/23\/11680"],"award-info":[{"award-number":["PG\/23\/11680"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbamcr.2026.120203","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:22:36Z","timestamp":1786033356000},"page":"120203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The EPAC inhibitor ESI-09 attenuates NF-\u03baB signalling in vascular cells"],"prefix":"10.1016","volume":"1873","author":[{"given":"Jolanta","family":"Wiejak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick G.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Burgoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Yarwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2026.120203_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37727","article-title":"Vascular smooth muscle cell phenotypic switching in atherosclerosis","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbamcr.2026.120203_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.737934","article-title":"Molecular interactions between vascular smooth muscle cells and macrophages in atherosclerosis","volume":"8","author":"Beck-Joseph","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00018-021-04079-z","article-title":"An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis","volume":"79","author":"Zhang","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0030","article-title":"NF-\u03baB signaling in inflammation, signal transduction and targeted therapy","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0035","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-011-0757-8","article-title":"Cyclic AMP: a selective modulator of NF-\u03baB action","volume":"68","author":"Gerlo","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0040","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.4049\/jimmunol.159.11.5450","article-title":"Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription","volume":"159","author":"Parry","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105030","article-title":"Blame the signaling: role of cAMP for the resolution of inflammation","volume":"159","author":"Tavares","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0050","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/j.1460-2075.1995.tb07191.x","article-title":"RelA\/p65 is a molecular target for the immunosuppressive action of protein kinase a","volume":"14","author":"Neumann","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bj3560525","article-title":"Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression","volume":"356","author":"Kamthong","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0060","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1074\/jbc.M605741200","article-title":"Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes","volume":"282","author":"Fraser","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000202","article-title":"Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105","volume":"2","author":"Wall","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091414","article-title":"Cyclic-AMP increases nuclear actin monomer which promotes proteasomal degradation of RelA\/p65 leading to anti-inflammatory effects","volume":"11","author":"Hawkins","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2026.120203_bb0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1152\/physrev.00025.2017","article-title":"Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development","volume":"98","author":"Robichaux","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yjmcc.2010.10.010","article-title":"PKA and Epac synergistically inhibit smooth muscle cell proliferation","volume":"50","author":"Hewer","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tips.2015.02.003","article-title":"The future of EPAC-targeted therapies: agonism versus antagonism","volume":"36","author":"Parnell","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1042\/BST20130271","article-title":"Interactions between Epac1 and ezrin in the control of endothelial barrier function","volume":"42","author":"Parnell","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12576-018-0631-7","article-title":"Epac1 deficiency inhibits basic fibroblast growth factor-mediated vascular smooth muscle cell migration","volume":"69","author":"Kato","year":"2019","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0100","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/ATVBAHA.115.306534","article-title":"Epac1 deficiency attenuated vascular smooth muscle cell migration and Neointimal formation","volume":"35","author":"Kato","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002038","article-title":"Structure-guided design of selective Epac1 and Epac2 agonists","volume":"13","author":"Schwede","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ncb874","article-title":"A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK","volume":"4","author":"Enserink","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111425","article-title":"Identification of a novel class of Benzofuran Oxoacetic acid-derived ligands that selectively activate cellular EPAC1","volume":"8","author":"Beck","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2026.120203_bb0120","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1021\/acs.jmedchem.9b02094","article-title":"Synthesis and biochemical evaluation of noncyclic nucleotide exchange proteins directly activated by cAMP 1 (EPAC1) regulators","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20607-8","article-title":"Protein interaction, cytotoxic, transcriptomic and proteomic responses to structurally distinct EPAC1 activators in HUVECs","volume":"12","author":"Wiejak","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0130","doi-asserted-by":"crossref","first-page":"44192","DOI":"10.1074\/jbc.M112.422956","article-title":"Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac","volume":"287","author":"Courilleau","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0135","article-title":"Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 \u201ctherapeutic window\u201d","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175645","article-title":"Epac as a tractable therapeutic target","volume":"945","author":"Slika","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.112.080689","article-title":"A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion","volume":"83","author":"Almahariq","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0150","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1038\/s41598-023-43221-8","article-title":"Vascular smooth muscle cells enhance immune\/vascular interplay in a 3-cell model of vascular inflammation","volume":"13","author":"Wiejak","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00849","article-title":"A novel triple-cell two-dimensional model to study immune-vascular interplay in atherosclerosis","volume":"10","author":"Noonan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0160","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1039\/D5SC02112J","article-title":"Elucidation of the mechanism of partial activation of EPAC1 allosteric modulators by Markov state modelling","volume":"16","author":"Hardie","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0165","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0170","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0175","first-page":"33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145160","article-title":"EPAC in vascular smooth muscle cells","volume":"21","author":"Wehbe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0185","doi-asserted-by":"crossref","first-page":"H1547","DOI":"10.1152\/ajpheart.01317.2007","article-title":"Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration","volume":"295","author":"Yokoyama","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0190","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1124\/jpet.107.119933","article-title":"Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1\/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1)","volume":"322","author":"Fang","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0195","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1016\/j.febslet.2005.07.080","article-title":"Epac1 regulates integrity of endothelial cell junctions through VE-cadherin","volume":"579","author":"Kooistra","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1091\/mbc.e06-10-0972","article-title":"Role of Epac1, an exchange factor for rap GTPases, in endothelial microtubule dynamics and barrier function","volume":"19","author":"Sehrawat","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2026.120203_bb0205","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1476-5381.2011.01808.x","article-title":"Regulation of the inflammatory response of vascular endothelial cells by EPAC1","volume":"166","author":"Parnell","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0210","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bbamcr.2019.06.013","article-title":"Elevated cyclic-AMP represses expression of exchange protein activated by cAMP (EPAC1) by inhibiting YAP-TEAD activity and HDAC-mediated histone deacetylation","volume":"1866","author":"Ebrahimighaei","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0215","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2013.09.107","article-title":"The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1)","volume":"440","author":"Courilleau","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-8-1","article-title":"Transcriptional profiling of the LPS induced NF-kappaB response in macrophages","volume":"8","author":"Sharif","year":"2007","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315018","article-title":"Assessing how residual errors of scoring functions correlate to ligand structural features","volume":"23","author":"Shulga","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0245","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.15420\/ecr.2023.10","article-title":"Nuclear factor-\u03baB is a prime candidate for the diagnosis and control of inflammatory cardiovascular disease","volume":"18","author":"Matsumori","year":"2023","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0250","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1046\/j.1432-1033.2002.03157.x","article-title":"Inhibition of the NF-kappaB transcriptional activity by protein kinase A","volume":"269","author":"Takahashi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0255","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1074\/jbc.M710285200","article-title":"AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65","volume":"283","author":"Gao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-\u03baB subunits by phosphorylation","volume":"5","author":"Christian","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2026.120203_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121213","article-title":"Stability, pharmacokinetics, and biodistribution in mice of the EPAC1 inhibitor (R)-CE3F4 entrapped in liposomes and lipid nanocapsules","volume":"610","author":"Toussaint","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0270","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000224","article-title":"Control of NF-kappaB-dependent transcriptional responses by chromatin organization","volume":"1","author":"Natoli","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0280","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbamcr.2018.11.004","article-title":"The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs)","volume":"1866","author":"Wiejak","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0285","doi-asserted-by":"crossref","first-page":"H776","DOI":"10.1152\/ajpheart.00570.2012","article-title":"SOCS3 promotor hypermethylation and STAT3-NF-\u03baB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells","volume":"304","author":"Dhar","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0290","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/me.2005-0301","article-title":"Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6\/TAK1 complex","volume":"20","author":"Frob\u00f8se","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cmi.2013.36","article-title":"SOCS3 dictates the transition of divergent time-phased events in granulocyte TNF-\u03b1 signaling","volume":"11","author":"Chhabra","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0300","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1161\/ATVBAHA.119.314238","article-title":"Epac1 (exchange protein directly activated by cAMP 1) upregulates LOX-1 (oxidized low-density lipoprotein receptor 1) to promote foam cell formation and atherosclerosis development","volume":"40","author":"Robichaux","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106690","article-title":"Estrogen increases expression of vascular alpha 2C adrenoceptor through the cAMP\/Epac\/JNK\/AP-1 pathway and potentiates cold-induced vasoconstriction","volume":"131","author":"Fardoun","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0000000000001489","article-title":"GPER acts through the cAMP\/Epac\/JNK\/AP-1 pathway to induce transcription of alpha 2C adrenoceptor in human microvascular smooth muscle cells","volume":"82","author":"Fardoun","year":"2023","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0315","first-page":"C499","article-title":"Cyclic AMP-Rap1A signaling activates RhoA to induce \u03b1(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells","volume":"303","author":"Jeyaraj","year":"2012","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.bbamcr.2026.120203_bb0320","article-title":"Delocalization of endogenous A-kinase antagonizes Rap1-rho-\u03b1(2C)-adrenoceptor signaling in human microvascular smooth muscle cells","volume":"1","author":"Motawea","year":"2014","journal-title":"J Cytol Mol Biol"},{"key":"10.1016\/j.bbamcr.2026.120203_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/srep03032","article-title":"Epac-inhibitors: facts and artefacts","volume":"3","author":"Rehmann","year":"2013","journal-title":"Sci. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:53:35Z","timestamp":1794318815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0167488926001023"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120203","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The EPAC inhibitor ESI-09 attenuates NF-\u03baB signalling in vascular cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120203"}}